Close Menu

gastrointestinal disease

The product introduction comes about two years after the company merged with AmpliDiag and Genewave.

A team tracking gut microbial communities over time in premature infants found distinct microbial dynamics related to the timing of necrotizing enterocolitis onset.

Metanome will perform metagenomics analyses on samples collected using Companion PBx's Dx Fingerprint kit, a product that highlights deficiencies in pets' GI health.

Genetic Analysis CEO Kari Stenersen said the deal is a "commercial breakthrough" for the Oslo-based company.

Rebiotix will use Genetic Analysis' microarray-based GA-map dysbiosis test for use in its R&D programs for gastrointestinal diseases.

BioMérieux's BioFire Diagnostics subsidary and Cepheid sponsored presentations at the American Association for Molecular Pathology annual meeting in which clinical users shared preliminary data on highly anticipated products from the companies.

BioMérieux's planned acquisition of Salt Lake City, Utah-based BioFire Diagnostics for $450 million plus undisclosed debt, announced earlier this week, will give the French clinical diagnostics firm a US-based "hub" for molecular diagnostics that it plans to not only keep intact

BioFire Diagnostics has been awarded $1.4 million from the National Institutes of Health for the first year of a planned three-year project to clinically validate the company's FilmArray gastrointestinal panel and help shepherd it through the US Food and Drug Administration appro

Norwegian molecular diagnostics firm Genetic Analysis announced two new developments last week. The first was the appointment of Kari Stenerson, a former Axis-Shield marketing director, as its new CEO.

The story has been updated to correct the market size figure for BioFire Diagnostics' GI and respiratory tests and to correct the previous name of the company.

Pages

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.